Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women
Author(s) -
Amita Gupta,
Grace Montepiedra,
Lisa Aaron,
Gerhard Theron,
Katie McCarthy,
Sarah Bradford,
Tsungai Chipato,
Tichaona Vhembo,
Lynda StranixChibanda,
Carolyne OnyangoMakumbi,
Gaerolwe Masheto,
Avy Violari,
Blandina T. Mmbaga,
Linda Aurpibul,
Ramesh Bhosale,
Vidya Mave,
Vanessa Rouzier,
Anneke C. Hesseling,
Katherine Shin,
Bonnie Zimmer,
Diane Costello,
Timothy R. Sterling,
Nahida Chakhtoura,
Patrick JeanPhilippe,
Adriana Weinberg
Publication year - 2019
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1813060
Subject(s) - isoniazid , medicine , human immunodeficiency virus (hiv) , antiretroviral therapy , tuberculosis , pregnancy , obstetrics , immunology , viral load , pathology , biology , genetics
The safety, efficacy, and appropriate timing of isoniazid therapy to prevent tuberculosis in pregnant women with human immunodeficiency virus (HIV) infection who are receiving antiretroviral therapy are unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom